Cite
HARVARD Citation
Cleland, J. et al. (2021). The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. European heart journal. pp. 684-696. [Online].